Synthetic biology platform with a core mission to drive bio-based, sustainable solutions to address the most pressing planetary issues through innovation & exploration
Octarine Bio has raised €13M across 4 funding rounds from 10 investors, most recently a round in Jan 2026. Based in Copenhagen, Denmark; founded 2018; active in Cleantech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2026-01-22 | Other | €5.0M | Business Angels,dsm-firmenich Ventures,Edaphon,Oskare Capital,Per Falholt,Steen Riisgaard+2 more | View deal → |
| 2023-11-08 | Other | €4.3M | DSM-Firmenich Venturing,Oskare Capital,The Footprint Firm,Unconventional Ventures | View deal → |
| 2022-09-21 | Seed | €2.0M | DSM Venturing,Oskare Capital | View deal → |
| 2020-11-13 | Other | €1.5M | — | View deal → |
